W., Jr., Cestari, D., Mallery, R., Abbasi, B., Bouffard, M., Chwalisz, B
Strong quarter: Gland Pharma said Q4 FY '26 was its strongest quarter yet, with revenue up 22% year-on-year to INR 17,428 million and adjusted EBITDA up to INR 5,244 million
Any off-label use should comply with applicable laws and be conducted under appropriate medical supervision
High-fat dairy: Full-fat cheese in large amounts, heavy cream, butter-heavy dishes
Without adequate bulk, stool can sit in the colon for days, leading to the hard, dry, difficult-to-pass bowel movements that many semaglutide users report
Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway